Cardiovascular Morbidity in Diabetic Non-Alcoholic Fatty Liver Disease (NAFLD) Using NAFLD Fibrosis Score as an Early Indicator
Priti SHAHAPURE, Shimpa SHARMA
(Endocrinol Res Pract 2020; 24: 314-320) DOI: 10.25179/tjem.2020-77679
Priti SHAHAPURE, Shimpa SHARMA
(Endocrinol Res Pract 2020; 24: 314-320) DOI: 10.25179/tjem.2020-77679
Sibel Ertek, Arrigo Cicero, Gürbüz Erdoğan
(Endocrinol Res Pract 2012; 16: 85-88) DOI: 10.4274/Tjem.1924